CHRNB2 anticorps
-
- Antigène Voir toutes CHRNB2 Anticorps
- CHRNB2 (Cholinergic Receptor, Nicotinic, beta 2 (Neuronal) (CHRNB2))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CHRNB2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- Antibody is purified by peptide affinity chromatography method.
- Immunogène
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human CHRNB2.
- Top Product
- Discover our top product CHRNB2 Anticorps primaire
-
-
- Indications d'application
- CHRNB2 antibody can be used for detection of CHRNB2 by ELISA at 1:312500. CHRNB2 antibody can be used for detection of CHRNB2 by western blot at 5.0 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 ?L of distilled water. Final antibody concentration is 1 mg/mL.
- Concentration
- 1 mg/mL
- Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
- Conseil sur la manipulation
- As with any antibody avoid repeat freeze-thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store CHRNB2 antibody at -20 °C.
-
- Antigène
- CHRNB2 (Cholinergic Receptor, Nicotinic, beta 2 (Neuronal) (CHRNB2))
- Autre désignation
- CHRNB2 (CHRNB2 Produits)
- Synonymes
- anticorps EFNL3, anticorps nAChRB2, anticorps NACHRB2, anticorps Acrb-2, anticorps Acrb2, anticorps C030030P04Rik, anticorps [b]2-nAchR, anticorps cholinergic receptor nicotinic beta 2 subunit, anticorps cholinergic receptor nicotinic beta 2 subunit S homeolog, anticorps cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), anticorps CHRNB2, anticorps chrnb2.S, anticorps Chrnb2
- Sujet
- Mutations in nAChRs are found in a rare form of nocturnal frontal lobe epilepsy . Previously, some nAChR mutations have been described that are associated with additional neurological features such as psychiatric disorders or cognitive defects. A new CHRNB2 mutation located in transmembrane region 3 (M3), outside the known ADNFLE mutation cluster. The CHRNB2 mutation I312M, which occurred de novo in twins, markedly increases the receptor's sensitivity to acetylcholine. Phenotypically, the mutation is associated not only with typical ADNFLE, but also with distinct deficits in memory. The cognitive problems are most obvious in tasks requiring the organization and storage of verbal information.
- Poids moléculaire
- 57 kDa
- ID gène
- 1141
- NCBI Accession
- NP_000739
- UniProt
- P17787
- Pathways
- Sensory Perception of Sound, Feeding Behaviour
-